Sfoglia per RIVISTA
LANCET (LONDON, ENGLAND)
Collezione AOU Alessandria

  

Items : 5

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. in Lancet (London, England) / Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2.

2024
AOU Alessandria

Ladetto M; Unterhalt M; Schmidt C; Gözel D; Klapper W; Pott C; Dierlamm J; Hanoun C; Hänel M; Benedetti F; Sonnevi K; Herhaus P; Novak U; Zinzani PL; Wirths S; van Meerten T; Visco C; Hess G; Arcaini L; Celli M; Jachimowicz RD; Kerkhoff A; Jiang L; Stilgenbauer S; Leppä S; Shpilberg O; Gomes da Silva M; Vergote V; Mey U; et alii...

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. in Lancet (London, England) / Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.

2024
AOU Alessandria

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. in Lancet (London, England) / Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.

2024
AOU Alessandria

Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. in Lancet (London, England) / Lancet. 2024 May 18;403(10440):2057-2099. doi: 10.1016/S0140-6736(24)00550-6. Epub 2024 Mar 20.

2024
AOU Alessandria

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. in Lancet (London, England) / Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3.

2023
AOU Alessandria

Seymour L; Scherpereel A; Bradbury P; Laurie SA; Tsao MS; Luo Y; Lantuejoul S; Brown-Walker P; Lee CW; Leighl N; Sederias J; Tu D; Gargiulo P; Delfanti S; Westeel V; Quantin X; Gridelli C; Zalcman G; Goffin JR; Sanchez ML; Pagano M; Dawe DE; Zucali PA; Ceresoli GL; Cecere FL; Mencoboni M; Morabito A; Florescu M; Lo Russo G; et alii...